Given the reported recent history of product performance issues via thousands of patient complaints on Philips Respironics CPAP machines, it is logical to imply that the delayed and insufficient action to address field issues ties to business culture and decision making deficiencies at Philips.

However, in need of a formal corrective action to their product field performance issues, Philips corporate leadership has apparently elected to close two manufacturing operations (“Philips Respironics to move manufacturing operations to Thailand, slashing hundreds of local jobs,” Oct. 27).

Moving manufacturing to a third party, low cost manufacturer in Thailand — away from design engineers, suppliers, customers, clinicians and FDA regional offices — doesn’t appear to be a solution to address product problems. Moving to a contract manufacturer only adds complexity and delays to building high quality medical devices.

Hopefully, there is time and openness for Philips corporate staff to rethink the implications of overseas outsourcing and instead leverage the teams and operations they have in and around Murrysville that are more than capable of world class performance.

Advertise with us

Jim Quasey

The writer is a former employee of Respironics, serving as vice president of operations until 2000.